*Mitigating Diabetic Foot Ulcers: The Effect of Diet and Microbiome DOI: http://dx.doi.org/10.5772/intechopen.106629*

[46] Verbeke KA, Boobis AR, Chiodini A, Edwards CA, Franck A, Kleerebezem M, et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutrition Research Reviews. 2015;**28**(1):42-66

[47] Morais CA, de Rosso VV, Estadella D, Pisani LP. Anthocyanins as inflammatory modulators and the role of the gut microbiota. The Journal of Nutritional Biochemistry. 2016;**33**:1-7

[48] Molinaro A, Bel Lassen P, Henricsson M, Wu H, Adriouch S, Belda E, et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nature Communications. 2020;**11**(1):5881

[49] Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of Gut Microbiota in the development of obesity and Diabetes. Lipids in Health and Disease. 2016;**15**:108

[50] Albenberg LG, Wu GD. Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology. 2014;**146**(6):1564-1572

[51] Galipeau HJ, Verdu EF. Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes. 2014;**5**(5):594-605

[52] Macfarlane S, Macfarlane GT, Cummings JH. Review article: Prebiotics in the gastrointestinal tract. Alimentary Pharmacology & Therapeutics. 2006;**24**(5):701-714

[53] Zaman M, Chin K, Rai V, Majid H. Fiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysis. World Journal of Gastroenterology. 2015;**17**:5372-5381

[54] Rajendran VM, Binder HJ. Apical membrane Cl-butyrate exchange: Mechanism of short chain fatty acid stimulation of active chloride absorption in rat distal colon. The Journal of Membrane Biology. 1994;**141**(1):51-58

[55] Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;**7**(3):189-200

[56] Manokas T, Fromkes JJ, Sundaram U. Effect of chronic inflammation on ileal short-chain fatty acid/bicarbonate exchange. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2000;**278**(4):G585-G590

[57] Wong C, Harris PJ, Ferguson LR. Potential benefits of dietary fibre intervention in inflammatory bowel disease. International Journal of Molecular Sciences. 2016;**17**(6):919

[58] Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America. 2007;**104**(34):13780-13785

[59] Selkrig J, Wong P, Zhang X, Pettersson S. Metabolic tinkering by the gut microbiome: Implications for brain development and function. Gut Microbes. 2014;**5**(3):369-380

[60] Blaut M. Gut microbiota and energy balance: Role in obesity. The Proceedings of the Nutrition Society. 2015;**74**(3):227-234

[61] Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, et al. Metabolitesensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut

homeostasis through regulation of the inflammasome. Nature Communications. 2015;**6**:6734

[62] Daly K, Cuff MA, Fung F, Shirazi-Beechey SP. The importance of colonic butyrate transport to the regulation of genes associated with colonic tissue homoeostasis. Biochemical Society Transactions. 2005;**33**(Pt 4): 733-735

[63] Daly K, Shirazi-Beechey SP. Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA and Cell Biology. 2006;**25**(1):49-62

[64] Bultman SJ. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Molecular Nutrition & Food Research. 2016:1-12

[65] Toden S, Lockett TJ, Topping DL, Scherer BL, Watson EJ, Southwood JG, et al. Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxintreated rats. Cancer Biology & Therapy. 2014;**15**(11):1515-1523

[66] Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilan CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology. 2016;**7**:185

[67] Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism. 2011;**13**(5):517-526

[68] Sawzdargo M, George SR, Nguyen T, Xu S, Kolakowski LF, O'Dowd BF. A cluster of four novel human G proteincoupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochemical and

Biophysical Research Communications. 1997;**239**(2):543-547

[69] Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of biological chemistry. 2003;**278**(13):11312-11319

[70] Kuwahara A. Contributions of colonic short-chain Fatty Acid receptors in energy homeostasis. Frontier in Endocrinology (Lausanne). 2014;**5**:144

[71] Kaji I, Karaki S, Kuwahara A. Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion. 2014;**89**(1):31-36

[72] Kimura I, Inoue D, Hirano K, Tsujimoto G. The SCFA receptor GPR43 and energy metabolism. Frontiers in Endocrinology. 2014;**5**:85

[73] McNelis JC, Lee YS, Mayoral R, van der Kant R, Johnson AM, Wollam J, et al. GPR43 potentiates beta-cell function in obesity. Diabetes. 2015;**64**(9):3203-3217

[74] Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. Journal of Gastroenterology. 2016:1-8

[75] Pereira MA, Pins JJ. Dietary fiber and cardiovascular disease: Experimental and epidemiologic advances. Current Atherosclerosis Reports. 2000;**2**(6):494-502

[76] Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? Journal of Obesity. 2012;**2012**:879151

*Mitigating Diabetic Foot Ulcers: The Effect of Diet and Microbiome DOI: http://dx.doi.org/10.5772/intechopen.106629*

[77] Wu T, Tang Q, Yu Z, Gao Z, Hu H, Chen W, et al. Inhibitory effects of sweet cherry anthocyanins on the obesity development in C57BL/6 mice. International Journal of Food Sciences and Nutrition. 2014;**65**(3):351-359

[78] Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Medicine. 2014;**20**(2):159-166

[79] Patterson E, Cryan JF, Fitzgerald GF, Ross RP, Dinan TG, Stanton C. Gut microbiota, the pharmabiotics they produce and host health. The Proceedings of the Nutrition Society. 2014;**73**(4):477-489

[80] Ojo O, Feng QQ, Ojo OO, Wang XH. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients. 2020;**12**(11)

[81] Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity. 2008;**32**(11):1720-1724

[82] Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;**18**(1):190-195

[83] Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME. Systematic review of gut microbiota and major depression. Frontiers in Psychiatry. 2019;**10**:34

[84] Hu S, Wang Y, Lichtenstein L, Tao Y, Musch MW, Jabri B, et al. Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2010;**299**(6):G1266-G1275

[85] Liu T, Wang C, Wang YY, Wang LL, Ojo O, Feng QQ, et al. Effect of dietary fiber on gut barrier function, gut microbiota, short-chain fatty acids, inflammation, and clinical outcomes in critically ill patients: A systematic review and meta-analysis. JPEN Journal of Parenteral and Enteral Nutrition. 2021

[86] Fu X, Liu Z, Zhu C, Mou H, Kong Q. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria. Critical Review in Food Science and Nutrition. 2019;**59**(suppl. 1):S130-S152

[87] Hor PK, Pal S, Mondal J, Halder SK, Ghosh K, Santra S, et al. Antiobesity, antihyperglycemic, and antidepressive potentiality of rice fermented food through modulation of intestinal microbiota. Frontiers in Microbiology. 2022;**13**:794503

[88] Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. Journal of Translational Medicine. 2017;**15**(1):73

[89] Long J, Cai Q, Steinwandel M, Hargreaves MK, Bordenstein SR, Blot WJ, et al. Association of oral microbiome with type 2 diabetes risk. Journal of Periodontal Research. 2017;**52**(3):636-643

[90] Shin NR, Whon TW, Bae JW. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends in Biotechnology. 2015;**33**(9):496-503

[91] Fan Y, Han W. el al, Abnormal gut microbiota composition contributes

to the development of type 2 diabetes mellitus in db/db mice. Aging. 2019;**11**(22):10454-10467

[92] Stojanov S, Berlec A, Strukelj B. The influence of probiotics on the firmicutes/ bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 2020;**8**(11)

[93] MacGregor G, Smith AJ, Thakker B, Kinsella J. Yoghurt biotherapy: Contraindicated in immunosuppressed patients? Postgraduate Medical Journal. 2002;**78**(920):366-367

[94] Moudgil V, Rana R, Tripathi PK, Farooq U, Sehgal R, Khan MA. Coprevalence of parasitic infections and diabetes in Sub-Himalayan region of Northern India. International Journal of Health Science (Qassim). 2019;**13**(1):19-24

[95] Yan LH, Mu B, Pan D, Shi YN, Yuan JH, Guan Y, et al. Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes. The Journal of International Medical Research. 2020;**48**(7):300060520937866

[96] Feng X, Li XQ. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: A systematic review and meta-analysis. Aging (Albany NY). 2022;**14**(2):975-988

[97] Hosseininasab Nodoushan SA, Nabavi A. The interaction of *Helicobacter pylori* Infection and Type 2 Diabetes Mellitus. Advanced Biomedical Research. 2019;**8**:15

[98] Chen B, Wang Z, Wang J, Su X, Yang J, Zhang Q, et al. The oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients. Endocrine. 2020;**68**(3):564-572

[99] Matsha TE, Prince Y, Davids S, Chikte U, Erasmus RT, Kengne AP, et al. Oral microbiome signatures in diabetes mellitus and periodontal disease. Journal of Dental Research. 2020;**99**(6):658-665

[100] Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes and Immunity. 2002;**3**(5):235-249

[101] Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biology. 2019;**17**(1):83

[102] Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;**159**(4):789-799
